Neuronetics (STIM) Shares Outstanding (Diluted Average) (2019 - 2026)

Neuronetics (STIM) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $69.6 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 13.22% year-over-year to $69.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.6 million (up 13.22% YoY) and the FY2025 annual result came in at $66.0 million, up 107.82% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $69.6 million in Q1 2026 per STIM's latest filing, from $66.0 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $69.6 million in Q1 2026 and bottomed at $26.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $29.5 million (2024), against an average of $39.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) increased 2.52%; it then surged 124.88% in 2025.
• Tracing STIM's Shares Outstanding (Diluted Average) over 5 years: stood at $26.9 million in 2022, then grew by 6.54% to $28.7 million in 2023, then gained by 10.73% to $31.7 million in 2024, then surged by 107.82% to $66.0 million in 2025, then increased by 5.52% to $69.6 million in 2026.
• Per Business Quant, the three latest STIM Shares Outstanding (Diluted Average) figures stand at $69.6 million (Q1 2026), $66.0 million (Q4 2025), and $67.3 million (Q3 2025).

Peer Comparison